XFOR Message Board Post 10920356 | X4 Pharmaceuticals Inc.
home / stock / xfor / xfor message board
amarshall
(investorshangout)
Posted on: Mar/02/2022 03:30:55
Source: investorshangout
https://investorshangout.com/post/view?id=6354225
znewcar1: XFOR 20% v2,1M c1.80 f29,7M H1.9 ML1.31
News, Short Squeeze, Breakout and More Instantly...
-
BOSTON, April 30, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that it will be reporting financial results for the first quarter ended March 31, 2024 and providing...
-
The FDA approved on Monday X4 Pharmaceuticals Inc’s (NASDAQ:XFOR) Xolremdi (mavorixafor) capsules for use in patients 12 years of age and ...
-
XOLREMDI targets CXCR4 pathway dysfunction, the underlying cause of WHIM syndrome Breakthrough Therapy approval follows Priority Review of 4WHIM Phase 3 clinical trial data X4 granted Rare Pediatric Disease Priority Review Voucher (PRV) concurrent with approval Conferenc...